Healthtech Startups

StemCyte is a cord blood banking and regenerative therapeutics company offering private and public cord blood and cord tissue collection, processing, and cryopreservation for expectant families. It operates an FDA-licensed cGMP facility, supplies cord blood units to transplant centers worldwide, and develops cord blood-derived therapies.

1 investor

StemInov is a biotech developing WhartSep, an off-the-shelf stem cell therapy derived from umbilical cord (Wharton's jelly) cells with three complementary actions to treat severe pneumonia and sepsis. The company targets immune disorders and tissue repair as unmet medical needs.

1 investor

Stemline is an oncology-focused pharmaceutical company developing and commercializing cancer therapies, including ELZONRIS (tagraxofusp-erzs) for blastic plasmacytoid dendritic cell neoplasm and ORSERDU (elacestrant) for ER-positive, HER2-negative, ESR-1 mutated advanced or metastatic breast cancer. It is part of the Menarini Group, an international pharmaceutical and diagnostics company.

1 investor

Stemmatters is a Contract Development and Manufacturing Organisation (CDMO) focused on regenerative medicine, providing product and process development plus cGMP production and clinical translation of medicinal products. It supports customers with CMC activities, regulatory dossier preparation, and clinical batch release for investigational and advanced therapy medicinal products.

1 investor

Stem Pharm develops therapeutics using stem cell technology for disease treatment and drug discovery. The company serves pharmaceutical and biotech partners seeking advanced cell-based approaches to translational drug development.

1 investor

StemSight develops stem cell-based therapies to restore sight, focusing on treatments for corneal conditions such as limbal stem cell deficiency using pluripotent stem cells. The company, spun out of the Skottman Lab's Eye Regeneration Group, targets patients with untreatable eye diseases in collaboration with cornea clinicians.

1 investor

Sterilex develops sanitation, disinfection, and microbial control products for use in food processing facilities, water systems, and animal environments.

1 investor

Steth IO provides remote patient monitoring and telehealth technology that lets patients check vitals using a smartphone and share the data with primary care providers or specialists through a secured platform. Its combined hardware and software captures heart sounds for more accurate, objective diagnosis by displaying both audio and visual information.

1 investor

Stethy offers a platform with pre-built, validated AI workflow templates that healthcare and life-science organizations deploy without code to automate clinical processes such as documentation, pharmacovigilance, and compliance checks. Its models are fine-tuned for life-science data and include safety guardrails and proprietary adverse event detection to meet regulatory standards.

1 investor

Stiefel is a biopharmaceutical company that discovers, develops and delivers medicines and vaccines. Its R&D focuses on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.

1 investor

Stillwater Medical operates a hospital and medical center providing healthcare services—including urgent care, emergency care, orthopedics, obstetrics and gynecology, and cardiology—to patients across north-central Oklahoma.

1 investor

StimAire develops wearable, wireless, and miniaturized medical solutions for treating obstructive sleep apnea. The company serves patients and combines clinical expertise with device technology in the sleep-medicine space.

1 investor

StimCardio Medical develops a non-invasive, wrist-worn neuromodulation wearable that combines continuous cardiac and autonomic sensing with cloud-based analysis to deliver personalized therapy, initially targeting atrial fibrillation. The system is an investigational medical device for cardiac rhythm care that has not received regulatory clearance.

1 investor

StimLabs develops regenerative medicine products, including its Corplex P device, used by physicians for wound healing and complex clinical cases. The company markets a portfolio of regenerative technologies for patient care.

1 investor

StimuSIL is a medical device company developing subdermal photobiomodulation technology that uses patented methods to deliver light-based stimulation beneath the skin's melanin layer for dermatology and aesthetics indications. Its lead preclinical candidate targets androgenetic alopecia (hair loss), with a research pipeline covering vitiligo, psoriasis, wrinkles, cellulite, and acne scars.

1 investor

1 investor

Stitch Health builds care coordination and collaboration tools for healthcare teams. It operates as a SaaS platform in the consumer health services space.

1 investor

STM develops microneedle patch technology for painless, temperature-stable delivery of drugs, vaccines, and supplements to humans, animals, and for nutraceutical applications. The platform eliminates cold-chain storage requirements and enables single-application multi-dose delivery across therapeutic and preventative use cases.

1 investor

Stochastic builds multimodal AI agents ("thinking agents") for enterprise workflows, starting with healthcare administration, that understand requests, complete tasks across a company's systems, and learn processes over time. It offers a full-stack platform that can run in a customer's own cloud or data center, aimed at teams in complex, high-stakes industries.

1 investor

StockRx provides inventory management software for independent pharmacies and pharmacy groups, digitising the goods-in process and tracking deliveries, supplier performance, and dispensary profitability in real time. Its features include margin analysis, automated credit note and claims management, invoice-to-statement reconciliation, and compliance reporting.

1 investor

Storbie provides an integrated retail and engagement platform that helps community pharmacies and veterinary practices build an online presence, connecting them with industry groups and suppliers. The platform supports showcasing products and services, managing appointments, and promotion, with a stated focus on small businesses in New Zealand, Australia, and the United States.

1 investor

STRAFFR makes a smart resistance fitness band paired with a mobile app that guides and tracks strength workouts for home and travel exercisers. The German consumer fitness product is used by several thousand people across more than 30 countries.

1 investor

Straloo runs a clinical musculoskeletal (MSK) care program combining licensed physiotherapists, orthopedic specialists, and an app plus WhatsApp support to steer workers toward conservative treatment and reduce surgeries and work absences. It serves Brazilian corporate health payers (operadoras, self-managed plans, funds) and employers, offering NR-1 compliance, FAP management, and auditable clinical governance dashboards.

1 investor

Strata Skin Sciences develops and provides dermatology treatment devices, including the XTRAC excimer laser and VTRAC excimer lamp for psoriasis and vitiligo, and the TheraClearX photopneumatic system for acne. Its products serve professionals in dermatology, plastic surgery, and aesthetics.

1 investor